Exploring the clinical and biological significance of the cell cycle-related gene CHMP4C in prostate cancer
Abstract Background Prostate cancer (PCa) stands as the second most prevalent malignancy impacting male health, and the disease’s evolutionary course presents formidable challenges in the context of patient treatment and prognostic management. Charged multivesicular body protein 4 C (CHMP4C) partici...
Main Authors: | Xi Xiao, Zonglin Li, Qingchao Li, Liangliang Qing, Yanan Wang, Fuxiang Ye, Yajia Dong, Xiaoyu Di, Jun Mi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-08-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-024-01970-z |
Similar Items
-
CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy
by: Hongtuan Zhang, et al.
Published: (2023-06-01) -
Identification and validation of diagnostic and prognostic biomarkers in prostate cancer based on WGCNA
by: Xi Xiao, et al.
Published: (2024-09-01) -
The role and mechanism of CHMP4C in poor prognosis and drug sensitivity of lung adenocarcinoma
by: Chuan Xu, et al.
Published: (2025-03-01) -
Multidimensional Analysis of CHMP Family Members in Hepatocellular Carcinoma
by: Guo Y, et al.
Published: (2022-03-01) -
Identification of a Pyroptosis-Related Gene Signature and Effect of Silencing the CHMP4C and CASP4 in Pancreatic Adenocarcinoma
by: Chen Y, et al.
Published: (2022-03-01)